Skip to content

Rafael Holdings, Inc. RFL Class of Warrant or Right, Outstanding

Class of Warrant or Right, Outstanding at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s class of warrant or right, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s class of warrant or right, outstanding?
Rafael Holdings, Inc. (RFL) reported class of warrant or right, outstanding of $645.19K in Q1 2026.
How has Rafael Holdings, Inc.'s class of warrant or right, outstanding changed year-over-year?
Rafael Holdings, Inc.'s class of warrant or right, outstanding decreased by 39.1% year-over-year, from $1.06M to $645.19K.